卫光生物(002880.SZ)：前三季度净利润1.58亿元 同比减少13.60%

Core Viewpoint - Weigao Bio (002880.SZ) reported a decline in revenue and net profit for the first three quarters of 2025 compared to the previous year [1] Financial Performance - The company achieved an operating income of 791 million yuan, representing a year-on-year decrease of 7.40% [1] - The net profit attributable to shareholders was 158 million yuan, down 13.60% year-on-year [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 155 million yuan, a decrease of 12.67% year-on-year [1] - Basic earnings per share stood at 0.696 yuan [1]